...
首页> 外文期刊>International Journal of Reproduction, Contraception, Obstetrics and Gynecology >A 3 year retrospective study on gestational trophoblastic disease in a government obstetrical tertiary care centre
【24h】

A 3 year retrospective study on gestational trophoblastic disease in a government obstetrical tertiary care centre

机译:在政府产科三级护理中心进行的为期三年的妊娠滋养细胞疾病回顾性研究

获取原文

摘要

Background: The aim of this study is to assess the post diagnostic outcome of Gestational Trophoblastic Disease, a heterogeneous group of disorders, in a government obstetrical tertiary care centre. Methods: The study was conducted in the Institute of Obstetrics & Gynecology, Madras Medical College as a retrospective study. A total of 75 cases were studied over a 3 year period from January 2012 to December 2015. The parameters which were studied included age group, antecedent pregnancy, beta hCG values, histopathological types and Treatment profile. Results: Of the 75 cases, 55 cases (73%) were in the 21-39 age group. The spectrum of disorders that were studied included 69 cases of complete mole, 2 cases of partial mole, 1 case of twin pregnancy with single live foetus and partial mole, 1 case of triplet pregnancy with two live foetuses and partial mole, 1 case of epithelioid trophoblastic tumour and 1 case of choriocarcinoma. Of the 75 cases, 16 cases underwent chemotherapy. No mortality was observed during the study period. Conclusions: Close monitoring and follow up with beta hCG values is of utmost importance in the management of Gestational trophoblastic disease. In cases of gestational trophoblastic neoplasia (GTN), WHO/FIGO scoring should be done and managed with chemotherapy according to the risk assessment.
机译:背景:本研究的目的是评估政府产科三级护理中心妊娠滋养细胞疾病(一种异质性疾病)的诊断后结果。方法:该研究是在马德拉斯医学院的妇产科研究所进行的一项回顾性研究。在2012年1月至2015年12月的3年中共研究了75例病例。所研究的参数包括年龄组,前期妊娠,βhCG值,组织病理学类型和治疗情况。结果:在这75例病例中,有55例(73%)在21-39岁年龄段。研究的疾病范围包括69例完全性痣,2例部分性痣,1例单胎活胎和部分痣的双胎妊娠,1例三联体妊娠,两个活胎和部分痣的1例,上皮样物质1例滋养细胞肿瘤和绒毛膜癌1例。在75例中,有16例接受了化疗。在研究期间未观察到死亡率。结论:密切监测和跟踪βhCG值对妊娠滋养细胞疾病的治疗至关重要。对于妊娠滋养细胞赘生性肿瘤(GTN),应根据风险评估对WHO / FIGO评分并通过化学疗法进行管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号